NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Scantox Group acquires Gentronix, a world leader in genetic toxicology
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”). [...]
Gentronix recognised with King’s award after record international growth
Gentronix, a UK-based Contract Research Organisation (CRO) specializing in predictive toxicology, has been honoured with the King’s Award for Enterprise due to its remarkable internati [...]
Gentronix Expands Laboratory Facilities to Meet Demand
UK-based Contract Research Organisation (CRO) Gentronix – a leading specialist toxicology CRO – has announced the next phase in its ongoing growth plan with the opening of a brand-new [...]
BLOG
Gentronix contributes to innovative new Cancer Revolution Exhibit at Science and Industry Museum
Gentronix was contacted by the lead curator of the Cancer Revolution: Science, Innovation and Hope exhibition, who was looking to collaborate with specialists within the Genetic Toxico [...]
Regulatory genotoxicity testing for plant protection products
Agrochemicals are extensively tested for toxicology profiles, and evaluation doesn’t stop with the active substance. Metabolites (either those that may be present in food or water supp [...]
Detecting clastogens & aneugens – how determining mechanism supports follow up testing
Key Assessments In addition to assessing a chemical’s ability to induce mutations, typically using the bacterial Ames test, a key aspect of understanding risk to human health is assess [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.